Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Primary aldosteronism in diabetic subjects with resistant hypertension.

Primary aldosteronism in diabetic subjects with resistant hypertension. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Primary aldosteronism in diabetic subjects with resistant hypertension. Abstract Text:

    guillermo e umpierrezGuillermo E Umpierrez,paul canteyPaul Cantey,dawn smileyDawn Smiley,andres palacioAndres Palacio,diana temponiDiana Temponi,karen lusterKaren Luster,arlene chapmanArlene Chapman,guillermo e umpierrezGuillermo E Umpierrez,paul canteyPaul Cantey,dawn smileyDawn Smiley,andres palacioAndres Palacio,diana temponiDiana Temponi,karen lusterKaren Luster,arlene chapmanArlene Chapman,guillermo e umpierrezGuillermo E Umpierrez,paul canteyPaul Cantey,dawn smileyDawn Smiley,andres palacioAndres Palacio,diana temponiDiana Temponi,karen lusterKaren Luster,arlene chapmanArlene Chapman,

    OBJECTIVE: Despite the high prevalence of hypertension in patients with type 2 diabetes, the prevalence of primary aldosteronism in this population has not been determined. RESEARCH DESIGN AND METHODS: One hundred subjects with type 2 diabetes and resistant hypertension, defined as blood pressure > 140/90 mmHg despite the use of > or = 3 antihypertensive agents, were screened for primary aldosteronism. Screening was performed by measuring the plasma aldosterone (PAC)-to-plasma renin activity (PRA) ratio. Subjects with a PAC-to-PRA ratio > 30 ng x ml(-1) x h(-1) underwent confirmatory salt load testing. Diagnostic criteria included 24-h urine aldosterone > or = 12 microg during the 3rd day of the oral salt load or a PAC > or = 5 ng/dl after the 4-h intravenous saline load. RESULTS: Thirty-four subjects had a PAC-to-PRA ratio >30 ng x ml(-1) x h(-1). Fourteen subjects (14% [95% CI 7.2-20.8]) had a confirmed diagnosis of primary aldosteronism. Ninety-three patients were African Americans. There were no differences in age, glycemic control, and number of antihypertensive drugs between subjects with and without primary aldosteronism. Subjects with primary aldosteronism had lower serum potassium (3.7 +/- 0.4 vs. 4.0 +/- 0.4 mmol/l, P = 0.012), higher PAC (15.6 +/- 8 vs. 9.1 +/- 6 ng/dl, P = 0.0016), and higher PAC-to-PRA ratio (98 +/- 74 vs. 21 +/- 30 x ml(-1) x h(-1), P < 0.001) than patients without primary aldosteronism. CONCLUSIONS: Primary aldosteronism is common in diabetic patients with resistant hypertension, with a prevalence of 14%. Our results indicate that diabetic subjects with poorly controlled hypertension who are taking > or = 3 antihypertensive drugs should be screened for primary aldosteronism.

    Primary aldosteronism in diabetic subjects with resistant hypertension. Publishing Authors By Initials

    ge umpierrezGE Umpierrez,p canteyP Cantey,d smileyD Smiley,a palacioA Palacio,d temponiD Temponi,k lusterK Luster,a chapmanA Chapman,ge umpierrezGE Umpierrez,p canteyP Cantey,d smileyD Smiley,a palacioA Palacio,d temponiD Temponi,k lusterK Luster,a chapmanA Chapman,ge umpierrezGE Umpierrez,p canteyP Cantey,d smileyD Smiley,a palacioA Palacio,d temponiD Temponi,k lusterK Luster,a chapmanA Chapman,

    For similar investigative techniques: epidemiologic methods: data collection: vital statistics: morbidity: prevalence research abstracts see: investigative techniques: epidemiologic methods: data collection: vital statistics: morbidity: prevalence research

    PUBMED ID PMID:

    MEDLINE DATE:

    Primary aldosteronism in diabetic subjects with resistant hypertension. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Diabetes care

    VOLUME: 30

    Page Numbers: 1699-703

    Journal Abbreviation: Diabetes Care

    ISSN: 1935-5548

    DAY: 11

    MONTH: 04

    YEAR: 2007

    Primary aldosteronism in diabetic subjects with resistant hypertension. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7805975

    Primary aldosteronism in diabetic subjects with resistant hypertension. Keywords Mesh Terms:

    KEYWORDS: Prevalence

    MESH TERMS: etiology

    Chemical & Substance for Abstract: Primary aldosteronism in diabetic subjects with resistant hypertension. Information

    Substance Name: Antihypertensive Agents

    Registry Number: 0

    Grant and Affiliation Information for Primary aldosteronism in diabetic subjects with resistant hypertension.

    AFFILIATION: Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30303, USA. geumpie@emory.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIDDK

    GRANT: R03 DK073190-01

    ACRONYM: DK

    MEDLINETA: Diabetes Care

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Primary aldosteronism in diabetic subjects with resistant hypertension Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News